Trial NCT06469307
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
- Phase
- Not given
- Sponsor
- Dana-Farber Cancer Institute
- Conditions
- Blood Cancer; Leukemia
- Ages
- 18+ years
Eligibility criteria
Highlighted: restrictions our model extracted, each a verbatim quote (pink = excludes outright, blue = only under conditions).
CAB Participant Inclusion Criteria:
* Age 18 or older
* English speakingLanguage
* Ability to understand and willingness to provide oral consent
* DFCI patient who are in remission from a blood cancer >1 year will be preferred.
CAB Participant Exclusion Criteria:
* Adults unable to consent
* Individuals who are not yet adults (infants, children, teenagers <18 years old)
* Prisoners.
* Unwilling/unable to agree to maintaining the confidentiality of reviews and clinical trial materials, as outlined in Section 9.1
* Note 1: Patients and non-patient community members who are pregnant are eligible.Pregnancy This is a non-interventional study that meets the definition of minimal risk and poses no greater risk to pregnant individuals or fetuses. Pregnancy status will not be assessed.
* Note 2: English fluency is necessary as protocols being reviewed are written in English and cannot be feasibly translated to other languages within the time period necessary to complete timely reviews.
Investigator Participant Inclusion Criteria:
* Age 18 older
* English Speaking
* Site or Principal investigator
* Not a member of the research team
Restrictions found (2)
- LanguageOutrightinclusionShow in the text
- PregnancyConditionalexclusionShow in the text
Recruiting in Massachusetts
- Dana-Farber Cancer Institute · Boston, Suffolk County